Results for tag: "Milnacipran"

Milnacipran is a centrally acting serotonin-norepinephrine reuptake inhibitor (SNRI) used to treat major depressive disorder and fibromyalgia. It is a member of the SNRI class of drugs, which are used to treat depression and other mental health conditions by increasing the levels of serotonin and norepinephrine in the brain. Milnacipran is also used to treat chronic pain, including pain associated with fibromyalgia. It is available in both oral and intravenous forms. Milnacipran is a relatively new drug in the Central Nervous System (CNS) drug market, but it has been gaining traction in recent years. It is generally well-tolerated and has fewer side effects than other CNS drugs. It is also considered to be a safer alternative to tricyclic antidepressants, which can have serious side effects. Some of the companies in the Milnacipran market include Eli Lilly, Pfizer, and GlaxoSmithKline. Show Less Read more